Kalaris Therapeutics (KLRS) Misses Q3 EPS by 64c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/27/2026

1. NVDA
2. OKTA
3. CRM
4. CRWD
5. VEEV
6. P
7. KKR
8. HPQ
9. NTNX
10. SPY

Go back to Kalaris Therapeutics (KLRS) Misses Q3 EPS by 64c
(NASDAQ: KLRS) Delayed: 4.10 +0.02 (0.49%)
Previous Close $4.08    52 Week High $ 
Open $4.08    52 Week Low $ 
Day High $4.19    P/E N/A 
Day Low $4.00    EPS $ 
Volume 104,887